MK-1248
MK-1248 is a human IgG4 monoclonal antibody (mAb) targeting TNFSF18. MK-1248 enhances the proliferative response of tumor-infiltrating lymphocytes to anti-CD3 stimulation and promotes the production of anti-tumor-associated regulatory cytokines. MK-1248 can be used in solid tumors research[1].
Product Specifications
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[MK-1248]
References & Citations
[1]Geva R, et al. First-in-human phase 1 study of MK-1248, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors. Cancer. 2020 Nov 15;126 (22) :4926-4935.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF18/GITR/CD357
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6145304-01 0.1 mL
ZNF8 (Zinc Finger Protein 8, Zfp128, Zinc Finger Protein HF.18) (Biotin)
Sign In for Pricing
View Details MBS6145304-02 5x 0.1 mL
ZNF8 (Zinc Finger Protein 8, Zfp128, Zinc Finger Protein HF.18) (Biotin)
Sign In for Pricing
View Details 
K4536302 1.0 µg DNA
Eri3 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details MBS6146786-01 0.1 mL
DcR3 (Tumor Necrosis Factor Receptor Superfamily Member 6B, Decoy Receptor 3, DcR3, Decoy Receptor for Fas Ligand, M68, TNFRSF6B, TR6, UNQ186/PRO212) (FITC)
Sign In for Pricing
View Details